Literature DB >> 18279847

Opioid and nociceptin receptors regulate cytokine and cytokine receptor expression.

M J Finley1, C M Happel, D E Kaminsky, T J Rogers.   

Abstract

Opioids were originally discovered because of their ability to induce analgesia, but further investigation has shown that the opioids regulate the function of cells involved in the immune response. We suggest that the regulation of cytokine, chemokine, and cytokine receptor expression is a critical component of the immunomodulatory activity of the opioids. In this paper we review the literature dealing with the regulation of cytokine and cytokine receptor expression by agonists for the three major opioid receptor types (mu, kappa, and delta), and nociceptin, the natural agonist for the orphanin FQ/nociceptin receptor. Although the opioid receptors share a high degree of sequence homology, opposing roles between the kappa opioid receptor (KOR) and the mu opioid receptor (MOR) have become apparent. We suggest that activation of the KOR induces an anti-inflammatory response through the down-regulation of cytokine, chemokine and chemokine receptor expression, while activation of the MOR favors a pro-inflammatory response. Investigation into the opioid receptor-like (ORL1)/nociceptin system also suggests a role for this receptor as a down-regulator of immune function. These effects suggest a broad role for opioids in the modulation of the function of the immune system, and suggest possible targets for the development of new therapeutics for inflammatory and infectious diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18279847      PMCID: PMC2538679          DOI: 10.1016/j.cellimm.2007.09.008

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  96 in total

Review 1.  Modulation of immune function by morphine: implications for susceptibility to infection.

Authors:  Sabita Roy; Jinghua Wang; Jennifer Kelschenbach; Lisa Koodie; Josephine Martin
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 4.147

2.  Transforming growth factor beta induces the production of interleukin 6 by human peripheral blood mononuclear cells.

Authors:  M Turner; D Chantry; M Feldmann
Journal:  Cytokine       Date:  1990-05       Impact factor: 3.861

3.  Opioid peptides modulate production of interferon gamma by human mononuclear cells.

Authors:  S L Brown; D E Van Epps
Journal:  Cell Immunol       Date:  1986-11       Impact factor: 4.868

4.  Beta-endorphin regulates interleukin 1 production and release by murine bone marrow macrophages.

Authors:  R N Apte; J J Oppenheim; S K Durum
Journal:  Int Immunol       Date:  1989       Impact factor: 4.823

5.  Beta-endorphin binding to naloxone-insensitive sites on a human mononuclear cell line (U937): effects of cations and guanosine triphosphate.

Authors:  N A Shahabi; P K Peterson; B Sharp
Journal:  Endocrinology       Date:  1990-06       Impact factor: 4.736

6.  Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone.

Authors:  D T Lysle; M E Coussons; V J Watts; E H Bennett; L A Dykstra
Journal:  J Pharmacol Exp Ther       Date:  1993-06       Impact factor: 4.030

7.  Morphine regulates gene expression of alpha- and beta-chemokines and their receptors on astroglial cells via the opioid mu receptor.

Authors:  Supriya D Mahajan; Stanley A Schwartz; Thomas C Shanahan; Ram P Chawda; Madhavan P N Nair
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

8.  Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication.

Authors:  Amber D Steele; Earl E Henderson; Thomas J Rogers
Journal:  Virology       Date:  2003-04-25       Impact factor: 3.616

9.  beta-Endorphin augments the cytolytic activity and interferon production of natural killer cells.

Authors:  R N Mandler; W E Biddison; R Mandler; S A Serrate
Journal:  J Immunol       Date:  1986-02-01       Impact factor: 5.422

10.  ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization.

Authors:  C Mollereau; M Parmentier; P Mailleux; J L Butour; C Moisand; P Chalon; D Caput; G Vassart; J C Meunier
Journal:  FEBS Lett       Date:  1994-03-14       Impact factor: 4.124

View more
  50 in total

1.  Genome-wide genetic associations with IFNγ response to smallpox vaccine.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; V Shane Pankratz; Iana H Haralambieva; Robert A Vierkant; Robert M Jacobson; Gregory A Poland
Journal:  Hum Genet       Date:  2012-06-03       Impact factor: 4.132

2.  Influence of endogenous opioid systems on T lymphocytes as assessed by the knockout of mu, delta and kappa opioid receptors.

Authors:  Ali G Karaji; David Reiss; Audrey Matifas; Brigitte L Kieffer; Claire Gavériaux-Ruff
Journal:  J Neuroimmune Pharmacol       Date:  2011-09-22       Impact factor: 4.147

Review 3.  Immunology as it pertains to drugs of abuse, AIDS and the neuroimmune axis: mediators and traffic.

Authors:  Thomas J Rogers
Journal:  J Neuroimmune Pharmacol       Date:  2010-10-19       Impact factor: 4.147

4.  Neuroprotection by the kappa-opioid receptor agonist, BRL52537, is mediated via up-regulating phosphorylated signal transducer and activator of transcription-3 in cerebral ischemia/reperfusion injury in rats.

Authors:  Shudong Fang; Hui Xu; Junrui Lu; Yesen Zhu; Hong Jiang
Journal:  Neurochem Res       Date:  2013-08-31       Impact factor: 3.996

5.  Autoantibodies to the delta-opioid receptor function as opioid agonists and display immunomodulatory activity.

Authors:  Parvathi Ranganathan; Hao Chen; Miranda K Adelman; Samuel F Schluter
Journal:  J Neuroimmunol       Date:  2009-10-30       Impact factor: 3.478

6.  Transcriptional regulation of the major HIV-1 coreceptor, CXCR4, by the kappa opioid receptor.

Authors:  Matthew J Finley; Amber Steele; William D Cornwell; Thomas J Rogers
Journal:  J Leukoc Biol       Date:  2011-03-29       Impact factor: 4.962

Review 7.  Morphine: double-faced roles in the regulation of tumor development.

Authors:  X Y Zhang; Y X Liang; Y Yan; Z Dai; H C Chu
Journal:  Clin Transl Oncol       Date:  2017-11-10       Impact factor: 3.405

Review 8.  Current research on opioid receptor function.

Authors:  Yuan Feng; Xiaozhou He; Yilin Yang; Dongman Chao; Lawrence H Lazarus; Ying Xia
Journal:  Curr Drug Targets       Date:  2012-02       Impact factor: 3.465

9.  A review of opioid prescribing practices and associations with repeat opioid prescriptions in a contemporary outpatient HIV clinic.

Authors:  Nur F Önen; Ernie-Paul Barrette; Enbal Shacham; Toshibumi Taniguchi; Michael Donovan; Edgar T Overton
Journal:  Pain Pract       Date:  2011-11-22       Impact factor: 3.183

10.  Structure-function studies on non-synonymous SNPs of chemokine receptor gene implicated in cardiovascular disease: a computational approach.

Authors:  A Sai Ramesh; Rao Sethumadhavan; Padma Thiagarajan
Journal:  Protein J       Date:  2013-12       Impact factor: 2.371

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.